Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents

Expert Opin Investig Drugs. 2019 Dec;28(12):1021-1024. doi: 10.1080/13543784.2019.1692811. Epub 2019 Nov 18.

Authors

Muge Cevik¹, Chloe Orkin^{2

3}

Affiliations

¹ Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK.
² Blizard Institute, Queen Mary University of London, London, UK.
³ Royal London Hospital,Ambrose King Centre, Barts Health NHS Trust, London, UK.

PMID: 31738620
DOI: 10.1080/13543784.2019.1692811

No abstract available

Keywords: Capsid inhibitors; HIV; HIV-1; antiretrovirals; capsid assembly; capsid protein.

Publication types

Editorial

MeSH terms

Animals
Anti-HIV Agents / pharmacology*
Capsid Proteins / antagonists & inhibitors*
Drug Development
HIV Infections / drug therapy*
HIV Infections / virology
HIV-1 / drug effects
Humans

Substances

Anti-HIV Agents
Capsid Proteins